Funds and ETFs Daan Gene Co., Ltd.

002030

CNE000001KP1

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
6.99 ^CNY	-8.39%		-6.43%	-27.79%

Apr. 29	Daan Gene Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 26	Daan Gene Gets Nod to Register Detection Kit for Influenza Viruses, COVID-19	MT

ETFs positioned on Daan Gene Co., Ltd.

Name	Weight	AuM	1st Jan change	Investor Rating
KRANESHARES MSCI ALL CHINA HEALTH CARE INDEX UCITS ETF - USD	0.37%	2 M€	-12.62%	-
VANECK CHINA GROWTH LEADERS ETF - USD	0.22%	12 M€	-16.71%	-
GOLDMAN SACHS ACTIVEBETA EMERGING MARKETS EQUITY UCITS ETF - ACC - USD	0.07%	11 M€	+4.66%
LEADERSHARES EQUITY SKEW ETF - USD	0.00%	117 M€	+2.11%	-
DAY HAGAN/NED DAVIS RESEARCH SMART SECTOR INTERNATIONAL ETF - USD	0.00%	31 M€	+5.22%	-
UNLIMITED HFND MULTI-STRATEGY RETURN TRACKER ETF - USD	0.00%	34 M€	+2.67%	-
NOMURA NEXT FUNDS EMERGING MARKET EQUITY MSCI-EM (UNHEDGED) ETF - JPY	0.00%	15 M€	+12.19%

Da An Gene Co., Ltd. specializes in the development, manufacture and marketing of molecular diagnosis products for infectious and epidemic diseases. The group offers real-time polymerase chain reaction instruments (QPCR), immunological products, screening systems for cervical cancer, sequencing tools, blood collection tubes and food safety products.

Sector

Pharmaceuticals

Calendar

2024-05-15 - Extraordinary Shareholders Meeting

More about the company